|
MechanismDRDs antagonists |
|
Originator Org.- |
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.- |
First Approval Date- |
罗通定片随机、开放、剂量递增序贯单次以及多次的药代动力学研究
[Translation] A randomized, open-label, dose-escalation sequential single and multiple pharmacokinetic study of Rotundine tablets
考察中国健康成人单次和多次口服罗通定片的药代动力学特点及安全性
[Translation] To investigate the pharmacokinetic characteristics and safety of single and multiple oral administration of rotundine tablets in healthy Chinese adults
100 Clinical Results associated with Beijing Sihuan Pharmaceutical Technology Co. Ltd.
0 Patents (Medical) associated with Beijing Sihuan Pharmaceutical Technology Co. Ltd.
100 Deals associated with Beijing Sihuan Pharmaceutical Technology Co. Ltd.
100 Translational Medicine associated with Beijing Sihuan Pharmaceutical Technology Co. Ltd.